Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraoperative intravenous dextrose dose comparison for prevention of postoperative nausea and vomiting after rhinoplasty
IRCT20131228015963N10Phase 3Completed
- Sponsor
- Guilan University of Medical Sciences
- Start
- Jan 2024
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dextrose in postoperative nausea and vomiting (PONV) (3 arms), sponsored by Guilan University of Medical Sciences. Primary endpoints: Incidence of postoperative nausea and vomiting and Severity of postoperative nausea and vomiting. Started Jan 2024; status: completed.
02
Drugs
dextrose
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on IRCT20131228015963N10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20131228015963N10.